orally administered drug candidates designed to target well-defined molecular pathways, with an emphasis on translating foundational immunology research into clinical applications. Attivare Therapeutics conducts preclinical and clinical development activities, including target validation, medicinal chemistry, pharmacology, and safety evaluation. The company also engages in translational research to identify biomarkers that support patient selection and therapeutic monitoring. Through collaborations with academic researchers and industry partners, Attivare Therapeutics advances programs aimed at treating inflammatory, autoimmune, and immune-mediated conditions.